Retatrutide GLP-1 Isn't Approved. MILLIONS Are Already Using It RIGHT NOW.
The Infographics Show · 28:35 · Watch on YouTube
Retatrutide is Eli Lilly's experimental weekly injection that acts on three hormone receptors at once (GLP-1, GIP and glucagon). In trials it produced about 28–30% average weight loss with no plateau, which roughly ma...